Introduction
============

Olfaction in nematodes and vertebrates utilizes G protein-coupled receptor (GPCR) signaling. In insects, odorant receptor (OR) proteins share the seven-transmembrane topology of GPCRs but retain no sequence-similarity (Benton et al., [@B1]). Furthermore, they form heterodimers of a ligand-binding OR and an ubiquitous co-receptor such as Dmel/Orco (previously Or83b in *Drosophila*; Vosshall and Hansson, [@B23]), both of which are inversely oriented in the membrane compared to GPCRs (Benton et al., [@B1]; Lundin et al., [@B15]). On the other hand, G proteins are expressed in the dendrites of olfactory sensory neurons (OSNs) bearing the ORs (Boto et al., [@B2]), and *Drosophila* mutants with disturbed G protein signaling cascades show impaired odor processing (reviewed in Hansson et al., [@B11]). Here we concentrate on OR22a as ligand-binding receptor. This is probably the most well-investigated OR of *D. melanogaster*. It is expressed in large basiconic sensilla and is tuned to fruit volatiles (ethyl butyrate, ethyl hexanoate) emitted by, e.g., pineapple (Stensmyr et al., [@B22]; Hallem and Carlson, [@B9]).

Studies on insect OR function in heterologous expression systems provided evidence for a G protein-independent, ionotropic mode of action (Sato et al., [@B20]; Wicher et al., [@B25]). However, an additional metabotropic pathway has been shown to stimulate cAMP production, which in turn activates the ion channel-forming co-receptor protein Orco (Wicher et al., [@B25]). Manipulating the cAMP level changed the kinetics of the odor response in heterologous cells (Smart et al., [@B21]). Genetic manipulation of G protein signaling in flies produced comparatively mild effects on odor responses (Yao and Carlson, [@B26]). However, the important role of stimulatory G proteins and subsequent cAMP signaling was recently demonstrated both in flies and in the heterologous expression system (Deng et al., [@B6]). A consensus model of these controversial results suggests a modulation of the ionotropic response by metabotropic pathways (Nakagawa and Vosshall, [@B18]).

In addition to cAMP signaling, DAG/IP~3~ signaling may also play a role in insect olfaction (Krieger and Breer, [@B14]). Mutations in the *Drosophila dgq* gene encoding the G~q~ α subunit produces flies with reduced responses to odor stimulation (Kain et al., [@B12]). The responses were further attenuated by additional mutations in *plc21C*, a gene encoding for a PLCβ. In the present study, we investigate the effect of G~q~ protein downstream signaling on heterologously expressed Orco proteins and demonstrate the relevance of these results using single sensillum electrophysiology in *Drosophila* OSNs combined with microinjection of compounds affecting the G~q~ protein signaling cascade.

Materials and methods
=====================

PKC mutant Orco
---------------

Or83b protein kinase C (PKC) phosphorylation mutants M1, M2, and Orco PKC synthetic genes were generated and subcloned into *Eco*RI/*Xho*I sites of pcDNA3.1(+) plasmid (eurofins MWG operon, Ebersberg, Germany) and directly used for cell transfections. Sequences were analyzed by doublestrand DNA sequencing (eurofins MWG operon) and point mutations for M1 (S159N, T250N, S289N), M2 (T327N, T371N), and Orco PKC (S159N, T250N, S289N, T327N, T371N) verified. Expression and membrane targeting of Orco PKC was demonstrated by immunofluorescence. HEK293 cells were cultured on glass coverslips, transfected, and fixed in 4% PFA. Membranes were labeled with Texas Red-X conjugated wheat germ agglutinin (WGA; 5 μg/ml, Invitrogen). Cells were subsequently incubated with a primary rabbit polyclonal antibody (1:1000) against Orco (kindly provided by Leslie Vosshall) and an Alexa488 (1:1000) secondary antibody. Confocal images were taken and analyzed by LSM 510 Meta (Carl Zeiss, Germany).

Cell culture and transfection
-----------------------------

### Transient transfection

HEK293 cells were cultured at a density of \~2 × 10^4^ per 35-mm dish and transfected with 1 μg Or83b-pcDNA3.1(−) or 1 μg Or83b PKC-pcDNA3.1(+) using Roti-Fect transfection kit (Roth, Karlsruhe, Germany). In some experiments the partial Orco PKC mutants M1 and M2 were used (Figure [4](#F4){ref-type="fig"}A). To test for the role of G~s~ and G~q~ protein activation on Orco, cells were co-transfected with 1 μg hβ~2~ adrenergic receptor (β~2~ AR)/pCMV6-XL5 (Origene, Rockville, MD, USA) and with 1 μg hα~1~ adrenergic receptor (α~1~ AR)/pCMV6-XL4 (Origene). In all preparations with transient transfection cells were co-transfected with 0.5 μg EGFP; for electrophysiological experiments we only used cells showing GFP fluorescence (when illuminated at 470 nm) as indicator of putative OR expression.

### Stable transfection

The open reading frame of Orco was PCR-amplified using gene specific primers with restriction sites for XhoI and HindIII and cloned into the pcrII TA-cloning vector (Invitrogen, Carlsbad, CA, USA). The identity of the insert was sequenced in full length to verify identity and integrity and subcloned into the pcDNA3.1(+) expression vector via the integrated restriction sites. The resultant construct was verified by sequencing. Flp-In^™^-T-Rex^™^ 293 cells held in DMEM (high glucose, with l-Glutamine)/Ham's F12 (with l-Glutamine; PAA, Pasching, Austria) +10% FCS were transfected with OR 83b pc DNA 3.1 using Fugene (Invitrogen) according to the manufacterer's protocol. 24-h post-transfection 800 mg/l of G418 were added to the medium. After 12 weeks, clones were separated and tested for activity using measurements of channel activity as described (Wicher et al., [@B25]). The clone exhibiting the highest sensitivity to 8-bromo-cAMP was maintained under antibiotic selection and used for this study.

Patch-clamp electrophysiology
-----------------------------

Ion currents in HEK293 cells were measured at room temperature using whole-cell patch-clamp with appropriate compensation of series resistance and of capacitive currents. Additional experiments were performed in the inside-out configuration. Current measurements and data acquisition were performed using an EPC9 patch-clamp amplifier controlled by PatchMaster software (both HEKA Elektronik, Lambrecht, Germany). Patch-clamp pipettes were fabricated from borosilicate capillaries. Pipettes for whole-cell recordings had resistances of 2--4 MΩ for excised-patch recordings the pipette resistance was up to 15 MΩ.

The pipette solution contained (in mM) 140 KCl, 4 NaCl, 2.2 CaCl~2~, 2 Mg-ATP, 0.05 Na-GTP, 5 EGTA, 10 HEPES (pH 7.3), and the bath solution contained (in mM) 135 NaCl, 5 KCl, 1 CaCl~2~, 1 MgCl~2~, 10 HEPES, 10 glucose (pH 7.4). For recordings of inside-out patches the pipette solution was used for the bath and vice versa.

With the exception of GTP-γ-S, and GDP-β-S, which were applied via the patch pipette, all substances were applied to the bath using either a bath perfusion system (BPS4 from ALA, NY, USA) or a rapid solution changer (RSC160 from Biologic, Claix, France) which were controlled by the PatchMaster software (HEKA Elektronik).

For data analysis the software IgorPro (WaveMetrics, Lake Oswego, OR, USA) or Prism 4 (Graph Pad Software, San Diego, CA, USA) were used.

Extracellular single sensillum recording and microinjection
-----------------------------------------------------------

Recording and injection protocols were performed on Or22a-GAL4; UAS-CD8-GFP *Drosophila melanogaster* flies expressing membrane tagged GFP in Or22a-OSNs. Two- to 5-day-old adults were fixed dorsally to a microscope slide. Compounds and concentrations for injection were diluted in receptor lymph solution (Kaissling and Thorson, [@B13]) as follows: U73122 (0.5 mM), Gö6976 (0.5 mM), OAG (0.1 mM), PMA (0.1 mM). Note that due to a dilution effect, concentrations of injected agents were 100× the concentration used in whole-cell preparations. A microinjection setup consisting of a dual-pump system was used to inject agents via air pressure through the microelectrode holder and into the sensillum lymph. For odor stimulation, 10 μl of ethyl butyrate (99%, Sigma, Munich, Germany) in hexane (10 ng/μl; 99%, Fluka Analytical, Buchs, Switzerland) was pipetted onto 1 cm diameter filter paper disks and placed in disposable Pasteur pipettes. Odor stimuli were delivered at 0.5 l/min into a 1.0 l/min humidified air stream.

Sensilla were localized at 1000× magnification and an Ag/AgCl coated silver wire inserted into a sharpened glass capillary used to detect the extracellular analog signals originating from the OSNs. Action potentials were extracted digitally according to top--top amplitudes using Syntech Auto Spike 32 software. Cell activities were recorded for approximately 20 s before an initial 0.5 s stimulation with ethyl butyrate. Microinjection commenced at 100 s, and cells were again stimulated with an 0.5-s odor pulse after approximately 300 s. Responses of the larger amplitude Or22a-carrying cell were analyzed for 1500 ms after stimulus onset. For response kinetics, spike frequency ratios were analyzed as peri-stimulus time histograms (PSTHs) in 25 ms bins by dividing each 25 ms instantaneous spike frequency by the average pre-stimulus frequency over 2 s to give a normalized ratio for each time point. Areas under the PSTH curve were calculated for the stimulus (500 ms) and total response (1350 ms) windows respectively, adjusting for a 150 ms mechanical stimulus delay. These values were divided by time to establish a normalized frequency average for each response. Mann--Whitney *U* tests compared treatments with the control (receptor lymph ringer) after injection. All analyses were performed using PASW (SPSS) v. 18 software.

Chemicals
---------

8-Bromo-cAMP, 8-bromo-cGMP, dl-isoproterenol hydrochloride (ISO), dl-Norepinephrine hydrochloride (NE), ethyl butyrate (Etb), forskolin, GTP-γ-S, GDP-β-S, phorbol 12-myristate 13-acetate (PMA), and 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ22536) were obtained from Sigma (Taufkirchen, Germany); U73122, U73343 and Gö6976 from Calbiochem (Darmstadt, Germany); 1-oleoyl-2-acetyl-sn-glycerol (OAG) from Alexis (Lörrach, Germany).

Results
=======

Mutant flies with disrupted G~q~ protein/phospholipase C (PLC) signaling cascade show reduced odor responses (Kain et al., [@B12]). When seeking the molecular mechanism by which PLC inhibition affects the odor response, the most parsimonious assumption is that PLC targets the OR complex itself. As multiple receptors are affected by G~q~ protein disruption (Kain et al., [@B12]), the ubiquitous Orco would be a good target candidate. In human embryonic kidney (HEK293) cells co-expressing Or22a and Orco, we have previously observed that intracellular application of the non-hydrolysable G protein inhibitor GDP-β-S reduces the sensitivity of the receptor dimers to ethyl butyrate, a key ligand (Wicher et al., [@B25]). G protein inhibition prevented odor-induced cAMP production and consequent activation of Orco via the metabotropic pathway. Here, we asked whether inhibition of G proteins could affect the sensitivity of Orco to cAMP. Using the voltage-clamp technique in the whole-cell configuration, we perfused HEK293 cells expressing Orco with the non-hydrolysable GDP analog GDP-β-S via a patch pipette. Stimulation of Orco by bath application of the membrane-permeable cAMP analog 8-bromo-cAMP could -- even at the highest concentrations -- induce only a weak membrane current (Figure [1](#F1){ref-type="fig"}B). Without GDP-β-S in the pipette, 8-bromo-cAMP induced a current in a concentration-dependent manner (Figure [1](#F1){ref-type="fig"}B). Unexpectedly, permanent stimulation of G proteins with the non-hydrolysable GTP analog GTP-γ-S induced a current even in the absence of 8-bromo-cAMP (Figures [1](#F1){ref-type="fig"}A,B). Subsequent application of 8-bromo-cAMP further enhanced this current. However, there was less current production by 8-bromo-cAMP than under control conditions (287 pA vs. 550 pA; Figure [1](#F1){ref-type="fig"}B), indicating that the pool of channels available for activation by 8-bromo-cAMP is reduced due to pre-activation by GTP-γ-S.

![**G protein activity regulates the cAMP effect on Orco**. **(A)** Whole-cell current response in a non-transfected HEK293 cell on a voltage ramp from −100 to +100 mV after breaking into the cell (Control) and 2 min after application of 100 μM 8-br-cAMP (top), and a HEK293 cell expressing Orco after breaking into the cell (Control), after perfusion with GTP-γ-S (500 μM) to activate G proteins, and 2 min after application of 100 μM 8-br-cAMP (bottom). Note that 8-br-cAMP fails to produce a current in non-transfected cells. **(B)** Concentration--response curve for 8-br-cAMP-induced Orco currents, measured at −100 mV in the whole-cell mode with standard pipette solution (Control) and a solution containing GTP-γ-S (500 μM) to activate or GDP-β-S (500 μM) to inactivate G proteins, respectively. The current "before" is the difference between GTP-γ-S and Con described in **(A)**. (Control, *n* = 11; GTP-γ-S, *n* = 8, \*\**P* to Control \< 0.01; GDP-β-S, *n* = 9, \*\*\**P* \< 0.001). **(C)** Test for the role of G~s~ protein activation on Orco. Current responses in a cell expressing Orco and the β~2~ adrenergic receptor (β~2~ AR) to isoproterenol stimulation (10 μM) in the absence (ISO) and 6 min after application of SQ22536 (200 μM). Curves represent differences (2 min ISO -- before ISO). **(D)** Test for the role of G~q~ protein activation on Orco. Currents evoked in a cell expressing Orco and the α~1~ adrenergic receptor (α~1~ AR) by norepinephrine (NE) stimulation (1 μM) in the absence and 8 min after application of the PLC inhibitor U73122 (10 μM). Curves represent differences (2 min NE -- before NE).](fncel-05-00005-g001){#F1}

To assess whether G proteins have a direct effect on Orco and whether there is any subtype-specificity, we co-expressed Orco together with the β~2~-adrenergic receptor (β~2~-AR), which activates G~s~ proteins, and with the α~1~-adrenergic receptor (α~1~-AR), which activates G~q~ proteins. Stimulation of β~2~-AR with 10 μM isoproterenol induced currents of comparable size to those obtained after application of 1 μM 8-bromo-cAMP (relative current: 1.2 ± 0.2; *n* = 5). Preincubation of cells with the adenylyl cyclase inhibitor SQ22536 (200 μM) prevented current production by isoproterenol (relative current: −0.1 ± 0.1; *n* = 5; Figure [1](#F1){ref-type="fig"}C). Thus, neither the G~s~α subunit nor the βγ subunit complex was able to activate Orco in the absence of cAMP.

Stimulation of α~1~-AR with 1 μM norepinephrine induced currents of 1.6 ± 0.3 (*n* = 5), normalized to the 1 μM 8-bromo-cAMP response. To test for a direct G protein effect, PLC was inhibited with U73122 (10 μM). Under these conditions, norepinephrine failed to elicit a current (relative current: −0.2 ± 0.2; *n* = 7; Figure [1](#F1){ref-type="fig"}D), indicating that neither the G~q~α subunit nor the βγ subunit complex could activate Orco alone. The activation of co-expressed Orco upon stimulation of α~1~-AR is remarkable as it for the first time demonstrates that Orco can be metabotropically activated independent of cyclic nucleotides. There are thus at least two independent signaling pathways capable of producing Orco currents.

To examine whether inhibition of PLC activity could account for the reduced cAMP-sensitivity of Orco with GDP-β-S, we tested the effect of 8-bromo-cAMP in the presence of U73122. We then observed only marginal responses, even at the highest concentration of 8-bromo-cAMP (Figures [2](#F2){ref-type="fig"}A,C). U73343, an inactive analog of U73122, did not suppress the 8-bromo-cAMP effect (*P* = 0.91; *n* = 8). The G protein activity-dependence of the Orco response to cAMP is therefore related to either PLC activity or a downstream process, i.e., the response of Orco to cAMP requires some basal PLC activity. To maintain catalytic activity of PLC, physiologically free Ca^2+^ levels are necessary (Rebecchi and Pentyala, [@B19]). We thus tried to stimulate Orco using a Ca^2+^-free pipette solution, and we recorded only marginal responses to 8-bromo-cAMP (5 μM; 31 ± 17 pA; *n* = 9) or forskolin (10 μM; 95 ± 41 pA; *n* = 8) compared with those obtained with standard pipette solution (cAMP: 398 ± 67 pA; *n* = 11; forskolin: 697 ± 67 pA; *n* = 9).

![**Phospholipase C and protein kinase C activity regulates the cAMP effect on Orco**. **(A)** Current responses in a HEK293 cell expressing Orco on a voltage ramp from −100 to +100 mV after breaking into the cell (Control), after application of the PLC inhibitor U73122 (10 μM), and after application of 8-br-cAMP (100 μM) in presence of U73122. **(B)** Current responses in a cell expressing Orco before (Control) and after PMA (1 μM) and 8-br-cAMP stimulation (100 μM). **(C)** Concentration--response for 8-br-cAMP-induced Orco currents, measured as described in **(B)** with a standard bath solution (Control) and a solution containing U73122 (10 μM), the PKC inhibitor Gö6976 (2 μM) or the PKC activator PMA (1 μM), respectively. (Control, *n* = 10; U73122, *n* = 7, \*\*\**P* \< 0.001; Gö6976, *n* = 11, \*\**P* \< 0.01; PMA, *n* = 11, \*\**P* \< 0.01). **(D)** Concentration--response curves for cAMP-induced currents in inside-out patches from cells expressing Orco. Data represent maximum mean currents at −60 mV produced under control conditions and with 500 μM GDP-β-S, 10 μM U73122 or 1 μM Gö6976 in the bath. (Control, *n* = 13; GDP-β-S, *n* = 17, \*\*\**P* \< 0.001; U73122, *n* = 16, \*\*\**P* \< 0.001; Gö6976, *n* = 10, \*\*\**P* \< 0.001). The continuous curves are Hill fits described by EC~50~ values of 677 pM, 33 nM and 10 nM and Hill coefficients of 0.40, 0.33, and 0.51 for the control, GDP-β-S and U73122, respectively.](fncel-05-00005-g002){#F2}

Inhibition of PLC activity prevents PIP~2~ cleavage and subsequent IP~3~ and DAG production. We asked which of these effects could account for the observed depression of current production by cAMP. Mimicking PIP~2~ accumulation due to PLC inhibition using bath application of PIP~2~ with inside-out patches did not significantly reduce the cAMP effect (5 μM cAMP enhanced the background current of 3.6 ± 0.7 pA by 10 ± 2.7 pA; *n* = 8). Thus, the PIP~2~ cleavage products may instead be critical for the cAMP-sensitivity of Orco. Even though IP~3~ activated a tiny current (\~0.5 pA at 5 μM), this current was too weak to rescue the U73122-inhibited current, and it likely reflects the activation of an endogeneous HEK293 cell channel (Bugaj et al., [@B3]). By contrast, the DAG analog OAG enhanced the membrane current upon PLC inhibition (at 100 μM from 0.8 ± 0.2 pA to 2.6 ± 0.7 pA; *n* = 6), and partially restored sensitivity to cAMP (at 100 μM to 5.4 ± 1 pA; *n* = 6). DAG levels thus appear to control the response of Orco to cAMP. As DAG activates PKC, we assessed whether inhibition of PKC would mimic the effect of PLC inhibition. Application of 8-bromo-cAMP after preincubation of cells with the PKC inhibitor Gö6976 produced only weak whole-cell current responses that did not differ significantly from those obtained with U73122 (Figure [2](#F2){ref-type="fig"}C). On the other hand, activation of PKC with phorbol myristate acetate (PMA) induced an Orco current, while subsequent application of 8-bromo-cAMP caused only a mild further current increase (Figures [2](#F2){ref-type="fig"}B,C).

The concentration--response curve for whole-cell current activation by 8-bromo-cAMP indicates that Orco is highly sensitive to cAMP at physiological Ca^2+^ levels (Figures [2](#F2){ref-type="fig"}B,C). To demonstrate this directly we tested the effect of cAMP on inside-out patches. Intriguingly, current activation even after fast application of cAMP develops slowly and with a delay (Figure [3](#F3){ref-type="fig"}). The activation process thus differs from classical gating such as in CNG channels. The concentration--response curve obtained was characterized by EC~50~ = 0.7 nM cAMP and a Hill coefficient = 0.40 (Figure [2](#F2){ref-type="fig"}D). Therefore, Orco is at least four orders of magnitude more sensitive to cAMP than the most cAMP-sensitive CNG channel (Dhallan et al., [@B7]). As in the whole-cell experiments, GDP-β-S, U73122, and Gö6976 drastically reduced the responses to cAMP (Figure [2](#F2){ref-type="fig"}D).

![**Time course of Orco current activation**. **(A)** Current response upon cAMP stimulation (bold, mean of four excised patches, inside-out configuration, dashed, SEM). **(B)** Sample trace of an inside-out patch. Arrows mark application or wash of 500 pM cAMP as indicated.](fncel-05-00005-g003){#F3}

These results suggest that PKC activity plays a central role in controlling Orco function, and especially the sensitivity to cAMP. The Orco protein bears five PKC phosphorylation sites (Figure [4](#F4){ref-type="fig"}A), three in the intracellular loop 2 (IC2), T250, S289 and T327, and two with putative extracellular localization (S159 in EC2; T371 in EC3). To confirm the role of PKC-mediated phosphorylation, we produced an Orco PKC mutant with serine/threonine to asparagine replacements at all PKC sites (Figure [4](#F4){ref-type="fig"}A). This mutant was expected to mimic the Orco wild type in the presence of PLC or PKC inhibitors for both background activity and stimulation by cAMP. Odorant receptor heterodimers such as Or22a/Orco show some background activity even in the absence of odor stimuli (Wicher et al., [@B25]). Inside-out patches from HEK293 cells expressing Orco conducted a significantly higher resting current than those from non-transfected cells (Figure [4](#F4){ref-type="fig"}B), indicating that Orco is spontaneously active even in the absence of cAMP. The resting current was reduced by GDP-β-S, U73122, and Gö6976 (Figure [4](#F4){ref-type="fig"}B). For the PKC phosphorylation mutant Orco PKC, the resting current was similar to non-transfected cells and Orco-expressing cells in the presence of these inhibitors, and was significantly lower than for Orco-expressing cells under control conditions (Figure [4](#F4){ref-type="fig"}B). Compared to native Orco stimulation, activation of the mutant with 8-bromo-cAMP in the whole-cell configuration or cAMP in inside-out patches produced very weak responses (Figures [4](#F4){ref-type="fig"}C, [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). Similarly, PMA failed to elicit a current in the absence of 8-bromo-cAMP (Figure [5](#F5){ref-type="fig"}C).

![**Mutation of PKC phosphorylation sites in Orco reduces the resting current and cAMP responses**. **(A)** Scheme of Orco topology with mutations of PKC sites indicated in the three mutants Orco M1, Orco M2, and Orco PKC. Two sites are predicted to be in extracellular loops (ECL2 and ECL3) while three sites are in the intracellular loop 2. **(B)** Mean inward currents in inside-out patches from non-transfected HEK293 cells (*n* = 12), cells expressing Orco and Orco PKC, measured at −60 mV without stimulation. The constitutive current through Orco (Control, *n* = 43) was reduced by GDP-β-S; (500 μM, *n* = 13, \**P* \< 0.05, Student's *t*-test.), U73122 (10 μM; *n* = 10, \*\**P* \< 0.01), and Gö6976 (1 μM; *n* = 8, \**P* \< 0.05), and it is significantly larger than in patches from non-transfected HEK293 cells (\*\*\**P* \< 0.001). Compared with Orco PKC containing patches (*n* = 15), only the Orco current in the control is significantly larger (\**P* = 0.02). **(C)** Whole-cell current responses to 5 μM 8-br-cAMP in cells expressing Orco (WT) or the three PKC mutants, measured at −100 mV. (WT, *n* = 11; M1, *n* = 10; M2, *n* = 15; Orco PKC, *n* = 11; −4, \*\*\**P* \< 0.001; Student's *t*-test). Currents in M2 expressing cells are significantly larger than in M1 (\*\**P* = 0.002) or Orco PKC (\*\*\**P* \< 0.001) expressing cells. Error bars represent SEM. **(D)** Confocal micrographs of HEK293 cells transfected with Orco and Orco PKC. Green, immunofluorescence; red, Texas-red fluorescence of wheat germ agglutinine (WGA) labeled plasma membrane; bar, 10 μm; line indicates position of intensity profile shown in **(E)**. **(E)** Intensity profile of Orco and Orco PKC immunfluorescence and membrane staining (WGA-Texas-red) in two cells displayed in **(D)**. Colocalization of fluorescence signals indicates membrane insertion of the Orco proteins.](fncel-05-00005-g004){#F4}

![**Complete mutation of PKC phosphorylation sites in Orco disrupts cAMP responses**. **(A)** Whole-cell current response in a cell expressing Orco (top) and Orco PKC (bottom) on a voltage ramp from −100 to +100 mV after breaking into the cell (Con) and 2 min after application of 8-br-cAMP (100 μM). **(B)** Current recordings from excised patches (inside-out configuration) of a cell expressing Orco (top) and Orco PKC (bottom) after breaking into the cell (Control) and 2 min after application of cAMP at 500 pM and 100 μM, respectively. Patches were held at −60 mV, bars indicate current level. **(C)** Concentration--response curve for 8-br-cAMP-induced Orco and Orco PKC whole-cell currents, measured at −100 mV. (Orco, *n* = 10; Orco PKC, *n* = 13, \*\*\**P* \< 0.001). PMA (1 μM) was applied in the absence of 8-br-cAMP. (Orco, *n* = 11; Orco PKC, *n* = 10). **(D)** Concentration--response curve for cAMP-induced currents in inside-out patches from cells expressing Orco and Orco PKC. Data represent maximum mean currents, measured at −60 mV. (Orco, *n* = 13; Orco PKC, *n* = 13, \*\*\**P* \< 0.001).](fncel-05-00005-g005){#F5}

![**cAMP responses in Orco and Orco PKC**. All-point histograms for the data shown in Figure [5](#F5){ref-type="fig"}B. Currents from inside-out patches from a cell expressing Orco (top) and Orco PKC (bottom) after breaking into the cell (Control) and 2 min after application of cAMP at 500 pM and 100 μM, respectively. Patches were held at −60 mV, currents were recorded for 5 s (20 repetitions).](fncel-05-00005-g006){#F6}

To confirm that impaired membrane targeting of Orco PKC did not account for the small current production by cAMP, we tested the distribution of Orco and Orco PKC immunofluorescence in the HEK293 cells (Figure [4](#F4){ref-type="fig"}D). Comparison of immunostaining with plasma membrane staining indicated that both Orco and Orco PKC were localized within the membrane (Figures [4](#F4){ref-type="fig"}D,E).

We also designed two partial mutants (Figure [4](#F4){ref-type="fig"}A), mutant 1 (S159N, T250N, S289N) and mutant 2 (T327N, T371N) which both showed no resting activity. We next asked how their response to 8-bromo-cAMP compared to that of Orco and Orco PKC (Figure [4](#F4){ref-type="fig"}C). The weakest response was seen in the complete mutant Orco PKC; the response obtained with mutant 2 was significantly stronger than that of mutant 1 and Orco PKC itself (Figure [4](#F4){ref-type="fig"}C). This indicates that the various phosphorylation sites contribute to cAMP-sensitivity in additive manner, and the extent of Orco response to cAMP stimulation may thus be regulated by the degree of its phosphorylation via PKC.

To test whether PKC phosphorylation affects the odor response of OSNs in the fly, we combined extracellular recording of OSN activity upon odor stimulation with injection of compounds affecting PLC/PKC activity. For these experiments, a microelectrode was inserted into the antenna near the base of large basiconic ab3 sensilla housing OSNs expressing the receptor protein Or22a. These neurons were localized under fluorescence using the GAL4-UAS system to drive GFP expression in Or22a expressing neurons (Dobritsa et al., [@B8]). Stimulation with ethyl butyrate (Etb; log\[−5\] dilution) accelerated the firing frequency of the Or22a expressing neuron (A in Figures [7](#F7){ref-type="fig"}A,B; *f*~norm~ = 3.72 ± 0.73, stimulus window, *f*~norm~ = 2.37 ± 0.22, total response, *n* = 11) without affecting the other neuron B), as shown by Hallem et al. ([@B10]). Injection of the PLC inhibitor U73122 into sensilla diminished the response to Etb in comparison to sham injection (Figures [7](#F7){ref-type="fig"}A,C; *f*~norm~ = 2.52 ± 0.43, stimulus window, *n* = 13; *P* = 0.014, Mann--Whitney *U*). By contrast, the inactive analog U73343 had no effect (*f*~norm~ = 4.67 ± 1.04, stimulus window, *n* = 11, *P* = 0.870, Mann--Whitney *U*). The PKC inhibitor Gö6976 reduced the odor response in a manner similar to U73122 (Figures [7](#F7){ref-type="fig"}A,C; *f*~norm~ = 2.57 ± 0.43, stimulus window, *n* = 12; *P* = 0.023, Mann--Whitney *U*). By contrast, injection of the PKC activators OAG or PMA caused a robust increase of the Etb response (Figures [7](#F7){ref-type="fig"}B,D; *f*~norm~ = 7.06 ± 1.45 and 7.91 ± 1.17, respectively, total response, *n* = 8 and 10; *P* = 0.003 and \<0.001, Mann--Whitney *U*).

![**Modulation of PKC-mediated phosphorylation affects the odor response of *Drosophila* OSNs**. **(A,B)** Recordings of neuronal activity before and after Etb stimulation (−5 v/v; 0.5 s, bars) following injection of indicated compounds (Control, injection of receptor lymph solution). Etb stimulation enhances the activity of the A neuron but not of the B neuron. Inhibition of PLC (U73122) and PKC (Gö6976) reduces the Etb response of the A neuron **(A)** whereas activation of PKC (OAG, PMA) enhances the Etb response **(B)**. **(C)** Normalized spike frequency (*f*~norm~) of the A neuron upon Etb stimulation (0--0.5 s, at −5 v/v) after injection of receptor lymph solution (Control; *n* = 11), U73122 (*n* = 13), or Gö6976 (*n* = 12). Both treatments reduce the odor response (for *P* see text). **(D)** *f*~norm~ as described in **(C)** after injection of ringer solution (Control; *n* = 11) OAG (*n* = 8) or PMA (*n* = 10).](fncel-05-00005-g007){#F7}

Discussion
==========

Here we present evidence that the function of the odorant co-receptor Orco is controlled by its phosphorylation state via PKC. Regulation of ligand sensitivity by PKC phosphorylation has earlier been observed in, e.g., CNG channels. PKC activity can either enhance cGMP sensitivity (Müller et al., [@B16]) or reduce it (Müller et al., [@B17]). In the latter case the phosphorylation site was localized within the cGMP binding domain. Under normal physiological conditions the basal activity of PLC and PKC in HEK293 cells is sufficient to maintain Orco sensitivity to cAMP stimulation. Conditions leading to inhibition of these enzymes such as low free Ca^2+^ concentration suppress the activation of Orco by cAMP and thus may affect the odorant response. By contrast, high PLC/PKC activity would activate Orco independently of cAMP.

Inhibition of PLC function by GDP-β-S in HEK293 cells expressing Orco indicates constitutive activity of Orco--G~q~ protein pairs. Constitutive activity of GPCR-G protein pairs was, for example, reported in other receptors such as thromboxane receptors (Chillar et al., [@B4]) and mutations in adrenergic receptors (Cotecchia, [@B5]). In insect ORs, constitutive activity causing a receptor current in the absence of stimuli occurs in various heterologously expressed receptor heterodimers (Sato et al., [@B20]; Wicher et al., [@B25]), as well as in solely expressed Orco (Figure [4](#F4){ref-type="fig"}B). For Orco, background activity of PLC or PKC seems to be sufficient to maintain a phosphorylation state required for a constitutive activity (Figure [4](#F4){ref-type="fig"}B).

Odor stimulation of Or22a, either solely expressed or co-expressed with Orco in HEK293 cells, activated G~s~ proteins but not G~q~ proteins (Wicher et al., [@B25]). If this is a general rule (which remains to be shown), odorant responses would not induce G~q~ downstream signaling. This signaling cascade would thus be available to modulate OR function, for example by neuromodulators. The experiments using combined single sensillum recordings and microinjection demonstrate the significance of up- and down-regulation of PLC/PKC activity for the odor response of OSNs. Enzyme inhibition reduced the frequency dynamics of the OSN response, while stimulation of PKC produced a more robust and prolonged OSN response (Figure [7](#F7){ref-type="fig"}). A recent study utilizing similar extracellular recordings in transgenic flies with various G protein mutations failed to see any effect of G proteins on the *in vivo* olfactory response (Yao and Carlson, [@B26]). However, genetically manipulated animals could contain some counter-regulation of the metabotropic effects such as adaptation or up-regulation of regulating enzymes (e.g., phosphodiesterases). This can even occur during transient expression of constitutively active G proteins.

An unexpected result of the experiments with excised patches from HEK293 cells expressing Orco was the slow activation kinetics of the current after fast cAMP stimulation (Figure [3](#F3){ref-type="fig"}). The heterologous system may lack components that *in vivo* accelerate its activation. However, in the case that this slow time course of Orco activation would be similar in the OSNs, metabotropic signaling would not be able to contribute to the fast odor response of these neurons. For example, a 0.5-s odor pulse gives rise to a response terminating after 2 s (Figure [7](#F7){ref-type="fig"}), whereas the response of Orco to cAMP took tens of seconds to develop (Figure [3](#F3){ref-type="fig"}). It must be noted that the compound microinjection mimicked metabotropic signaling processes initiated in a temporal domain before the odor stimulation.

Our study was not designed to determine whether insect ORs are mixed ionotropic and metabotropic receptors (Wicher, [@B24]) or metabotropically modulated ionotropic receptors (Nakagawa and Vosshall, [@B18]). However, the PKC mutant of Orco provides a useful tool to address this question in future investigations that assess the relationship between ionotropic and metabotropic signaling.

Conclusion
==========

We have demonstrated a significant impact of the metabotropic pathway on olfactory response both in heterologous *in vitro* studies as well as in the *Drosophila* fly itself. Orco phosphorylation via PKC regulates OR sensitivity to cAMP, and therefore to odorants, and it may activate the receptor even in the absence of cAMP. This provides a powerful mechanism to adapt OR sensitivity not only via G~q~ proteins but also via free \[Ca^2+^\]~i~ levels.
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